[Congressional Record Volume 163, Number 7 (Wednesday, January 11, 2017)]
[Senate]
[Page S286]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 134. Mr. SANDERS (for himself, Ms. Stabenow, and Mr. Franken) 
submitted an amendment intended to be proposed by him to the concurrent 
resolution S. Con. Res. 3, setting forth the congressional budget for 
the United States Government for fiscal year 2017 and setting forth the 
appropriate budgetary levels for fiscal years 2018 through 2026; which 
was ordered to lie on the table; as follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO LOWERING 
                   PRESCRIPTION DRUG PRICES FOR AMERICANS BY 
                   IMPORTING DRUGS FROM CANADA AND OTHER 
                   COUNTRIES.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution 
     for one or more bills, joint resolutions, amendments, 
     amendments between the Houses, motions, or conference reports 
     relating to lowering prescription drug prices, including 
     through the importation of safe and affordable prescription 
     drugs by American pharmacists, wholesalers, and individuals 
     with a valid prescription from a provider licensed to 
     practice in the United States, by the amounts provided in 
     such legislation for those purposes, provided that such 
     legislation would not increase the deficit over either the 
     period of the total of fiscal years 2017 through 2021 or the 
     period of the total of fiscal years 2017 through 2026.
                                 ______